Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06513442
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-17
Brief Title:
The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADVANTAGE BONE
Brief Summary:
1 To assess the clinical utility of trabecular bone score TBS on fracture risk prediction including the new version TBS V4 and future TBS versions at the spine and hip
2 To assess the clinical utility of TBS software as a potential treatment outcome sensitivity to change over time and following osteoporosis therapy
3 To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography QCT in fracture risk prediction and response to osteoporosis therapy
2 To assess the clinical utility of TBS software as a potential treatment outcome sensitivity to change over time and following osteoporosis therapy
3 To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography QCT in fracture risk prediction and response to osteoporosis therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None